Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000156

CEO & President sold 15,202 shares at $447.00 ($6,795,294)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kewalramani Reshma · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-20 Sale : show line 1 in the form 10b5-1 −15,202 $447.00 $6,795,294 121,374 D
Open-market sales · 15,202 sh · avg $447.00 · $6,795,294
Loading xslF345X05/wk-form4_1716409296.xml…